Botulinum toxin, despite its potential for causing severe illness, has found therapeutic applications in various medical fields. Its ability to induce temporary muscle paralysis has led to its use in the treatment of conditions such as cervical dystonia, hyperhidrosis, and spasticity. Additionally, botulinum toxin injections are widely employed in cosmetic procedures to reduce wrinkles and fine lines by relaxing facial muscles. The therapeutic use of botulinum toxin requires careful consideration of patient selection, dosing, and administration techniques to minimize adverse effects. Safety is paramount in the use of botulinum toxin for therapeutic purposes. Healthcare professionals administering the toxin must be well-trained and adhere to established guidelines and protocols. Patient education is essential to ensure informed consent and proper understanding of potential side effects. While the therapeutic doses used are significantly lower than those causing botulism, adverse effects can still occur, including muscle weakness, bruising, and asymmetry. Research continues to explore new therapeutic applications for botulinum toxin and refine its use to maximize benefits while minimizing risks in both medical and cosmetic settings.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain